Heres what we know right now: It works for some people , particularly those with modest weight loss goals, GI sensitivity, or hormonal weight gain during menopause
Mechanisms underlying lung resistance-related protein (LRP)-mediated doxorubicin resistance of non-small cell lung cancer cells
In an exploratory posthoc analysis of the SURPASS-3 MRI substudy, results showed that patients treated with tirzepatide on top of metformin with/without an SGLT-2 inhibitor had a greater than predicted reduction of muscle fat
The three-year study of 1,032 adults showed that weekly injections of tirzepatide cut the risk of developing Type 2 diabetes by 94% in prediabetic adults who were overweight or obese, compared to placebo
Research also suggests that people who have lost moderate amounts of weight, rather than very large amounts, may experience less dramatic hormonal adaptations